Similar articles

• Effect of gonadotropin-releasing hormone agonists, nafarelin, buserelin, and leuprolide, on experimentally induced endometriosis in the rat.

  Mizutani T, Sakata M, Terakawa N. Mizutani T, et al. Int J Fertil Menopausal Stud. 1995 Mar-Apr;40(2):106-11. Int J Fertil Menopausal Stud. 1995. PMID: 7599657
• [Endometriosis: clinical, histological and morphometric findings before and after Gn-RH agonist therapy].

  Ruwe M, Donhuijsen K, Regidor PA, Leder LD, Schindler AE. Ruwe M, et al. Zentralbl Gynakol. 1998;120(8):391-8. Zentralbl Gynakol. 1998. PMID: 9757546 Clinical Trial. German.
• Quantification of endometriosis-associated pain and quality of life during the stimulatory phase of gonadotropin-releasing hormone agonist therapy: a double-blind, randomized, placebo-controlled trial.

  Miller JD. Miller JD. Am J Obstet Gynecol. 2000 Jun;182(6):1483-8. doi: 10.1067/mob.2000.106846. Am J Obstet Gynecol. 2000. PMID: 10871469 Clinical Trial.
• GnRH analogues in the treatment of endometriosis.

  Erickson LD, Ory SJ. Erickson LD, et al. Obstet Gynecol Clin North Am. 1989 Mar;16(1):123-45. Obstet Gynecol Clin North Am. 1989. PMID: 2526312 Review.
• [Endometriosis].

  Harada T. Harada T. Nihon Rinsho. 2006 Apr;64 Suppl 4:70-4. Nihon Rinsho. 2006. PMID: 16689287 Review. Japanese. No abstract available.